BioPharm Business News

Monday, July 06, 2009
IOM's Puts Arthritis Biologics Near Top of List for Comparative Studies
The Institute of Medicine puts biologic anti-inflammatory drugs near the top of its recommended list for comparative effectiveness studies...

Thursday, June 18, 2009
Biogen Gets Joint Control of Genentech Post-Rituxan Development
Genentech must stop three drug development projects but can continue lupus and RA ocrelizumab studies....

Monday, June 15, 2009
Waxman Wants to Let FDA OK Biosimilars Without Legal Authority
Rep. Henry Waxman asks White House to let FDA approve generic biologics...

Friday, June 05, 2009
FDA OKs 2-Year Reclast for Osteoporosis
Reclast (zoledronic acid) injection has been approved as the first therapy to prevent osteoporosis for 2 years with a single dose...

Friday, May 29, 2009
NIH Pops $24M into Orphan Diseases Research
NIH will put $24 million into a new program for developing drugs for rare and neglected diseases...

Thursday, May 28, 2009
Supreme Court to Hear Vioxx Case
The US Supreme Court will decide whether Merck should be protected from Vioxx shareholder suits...